You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中藥股普漲,多隻個股漲停

格隆匯3月30日丨中藥股今日早盤高開後快速回落,後又再度拉昇,截至午間收盤,貴州百靈、太安堂、龍津藥業漲停,盤龍藥業漲超8%,貴州三力漲超7%,此前漲停的華神科技漲幅收窄至逾3%,吉藥控股、精華製藥、特一藥業等紛紛走高。

國務院辦公廳印發《“十四五”中醫藥發展規劃》提出,鼓勵中藥材產業化、商品化和適度規模化發展,推進中藥材規範化種植、養殖。目標到2025年,中醫藥健康服務能力明顯增強,中醫藥高質量發展政策和體系進一步完善,中醫藥振興發展取得積極成效,在健康中國建設中的獨特優勢得到充分發揮。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account